Clinical Trials Browser

Phase 1 × TYRP1 protein, human × 90 days × Clear all

NCT03865212 2026-01-28

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Phase 1 Terminated

Uveal Melanoma, Melanoma